PARP1 and neoplasm: Thus, co‐treatment of GC (HS746T and AGS, with higher and lower expression of BRCA1/2 and c‐MET, respectively) cell lines with PARP and c‐MET inhibitors reduces cell viability through apoptosis and attenuated tumour growth in xenograft models.